NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT02973789,Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR),https://clinicaltrials.gov/study/NCT02973789,,COMPLETED,"The study is a prospective, randomized controlled phase III trial aimed to test the efficacy and safety of TTFields, using the NovoTTF-200T device, concurrent with standard therapies for stage 4 NSCLC patients, following progression while on or after platinum based treatment. The device is an experimental, portable, battery operated device for chronic administration of alternating electric fields (termed TTFields or TTF) to the region of the malignant tumor, by means of surface, insulated electrode arrays.",NO,Nonsmall Cell Lung Cancer|NSCLC,DEVICE: NovoTTF-200T|DRUG: Immune checkpoint inhibitors or docetaxel,"Overall survival of patients treated with TTFields + docetaxel or immune checkpoint inhibitors vs. docetaxel or immune checkpoint inhibitors alone (superiority analysis), 4 years","Overall survival of patients treated with TTFields + docetaxel vs. docetaxel alone (superiority analysis), 4 years|Overall survival of patients treated with TTFields + immune checkpoint inhibitors vs. immune checkpoint inhibitors alone (superiority), 4 years|Overall Survival of patients treated with TTFields + docetaxel Vs. immune checkpoint inhibitors alone (non-inferiority analysis), 4 years|Progression-free survival of patients treated with docetaxel or immune checkpoint inhibitors + TTFields vs. docetaxel or immune checkpoint inhibitors alone, based on RECIST Criteria, 4 years|Overall radiological response rate (based on RECIST criteria) of patients treated with docetaxel or Immune checkpoint inhibitors + TTFields vs. docetaxel or immune checkpoint inhibitors alone., 4 years|Quality of life using the EORTC QLQ C30 questionnaire with LC13 addendum, 4 years|Analyses of the effects of NovoTTF-200T with each type of immune checkpoint inhibitor on overall survival and progression free survival, 4 years|Analysis of the effects of NovoTTF-200T on overall survival and progression free survival within each histological subgroup (squamous and non-squamous), 4 years|The effect of treatment compliance with NovoTTF-200T on overall survival and progression free survival outcomes, 4 years|Adverse events, severity and frequency based on Common Terminology Criteria for Adverse Events (CTCAE) V4.03, 4 years",,NovoCure GmbH,,ALL,"ADULT, OLDER_ADULT",PHASE3,276,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,EF-24,2016-12,2024-09-24,2024-10-09,2016-11-25,,2024-10-21,"Central Alabama Research, Birmingham, Alabama, 35209, United States|Ironwood Cancer & Research Center, Chandler, Arizona, 85224, United States|Cancer Center at St. Joseph Hospital and Medical Center, Phoenix, Arizona, 85004, United States|Beverly Hills Cancer Center, Beverly Hills, California, 90211, United States|California Cancer Associates for Research and Excellence, Inc. cCARE, Fresno, California, 93720, United States|St. Joseph Heritage Healthcare, Fullerton, California, 92835, United States|Saddleback Memorial Medical Center, Laguna Hills, California, 92653, United States|Redlands Community Hospital (Emad Ibrahim, MD, Inc.), Redlands, California, 92373, United States|Dignity Health - Mercy Cancer Centers, Sacramento, California, 95186, United States|Sutter Institute for Medical Research, Sacramento, California, 95816, United States|Innovative Clinical Research Institute, Whittier, California, 90603, United States|Banner MD Anderson Cancer Center at North Colorado Medical Center, Greeley, Colorado, 80631, United States|Associated Neurologists of Southern CT, P.C., Fairfield, Connecticut, 06824, United States|Washington Cancer Institute at MedStar Washington Hospital Center, Washington, District of Columbia, 20010, United States|GenesisCare USA, Jacksonville, Florida, 32204, United States|Mount Sinai Medical Center, Miami Beach, Florida, 33140, United States|Miami Cancer Institute, Miami, Florida, 33176, United States|AdventHealth Orlando, Orlando, Florida, 32804, United States|Adult Oncology Research, Orlando, Florida, 32806, United States|BRCR Medical Center INC, Plantation, Florida, United States|University of Illinois Cancer Center, Chicago, Illinois, 60612, United States|Illinois CancerCare, P.C., Peoria, Illinois, 61615, United States|Southern Illinois University, School of Medicine, Simmons Cancer Institute at SIU, Springfield, Illinois, 62702, United States|Franciscan Health Indianapolis, Indianapolis, Indiana, 46237, United States|University of Kansas Cancer Center, Westwood, Kansas, 66205, United States|Norton Cancer Institute, Louisville, Kentucky, 40202, United States|University Medical Center, Inc; DBA University of Louisville, Louisville, Kentucky, 40202, United States|LSU Health Sciences Center -New Orleans, New Orleans, Louisiana, 70112, United States|Tulane Cancer Center, New Orleans, Louisiana, 70112, United States|CHRISTUS Health, Shreveport, Louisiana, 71105, United States|Central Maine Medical Center, Lewiston, Maine, United States|University of Maryland School of Medicine, Baltimore, Maryland, 21201, United States|Tufts Medical Center, Division of Hematology and Oncology, Boston, Massachusetts, 02111, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Clinical Oncology Associates, Farmington Hills, Michigan, 48336, United States|Detroit Clinical Research Center, Farmington Hills, Michigan, 48336, United States|Saint Joseph Mercy Health System, Ypsilanti, Michigan, 48197, United States|HealthPartners Institute, Regions Cancer Care Center, Saint Paul, Minnesota, 55101, United States|Saint Luke's Cancer Institute, Kansas City, Missouri, 64111, United States|Washington University School of Medicine, Saint Louis, Missouri, 63110, United States|CHI Health Research Center, Omaha, Nebraska, 68124, United States|Oncology Hematology West, PC dba Nebraska Cancer Specialists, Omaha, Nebraska, 68130, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|OptumCare Cancer Care, Las Vegas, Nevada, 89102, United States|Renown Regional Medical Center Institute for Cancer, Reno, Nevada, 89502, United States|Presbyterian Cancer Center, Albuquerque, New Mexico, 87110, United States|New York-Presbyterian/Queens Radiation Oncology, Flushing, New York, 11355, United States|Northern Westchester Hospital, Mount Kisco, New York, 10549-3417, United States|Stony Brook Cancer Center, Stony Brook, New York, 11794, United States|Oncology Specialists of Charlotte, Charlotte, North Carolina, 28204, United States|W.G. Bill Hefner VA Med Center, Salisbury, North Carolina, 28144, United States|Piedmont Radiation Oncology, PA, Winston-Salem, North Carolina, 27103, United States|Summa Health, Akron, Ohio, 44304, United States|Toledo Clinic Cancer Center, Toledo, Ohio, 43623, United States|Vita Medical Associates, P.C., Bethlehem, Pennsylvania, 18015, United States|Geisinger Cancer Institute, Danville, Pennsylvania, 17822, United States|UT/Erlanger Oncology & Hematology, Chattanooga, Tennessee, 37403, United States|Texas Oncology - Amarillo, Amarillo, Texas, 79106, United States|Texas Oncology - Arlington, Arlington, Texas, 76012, United States|Christus Health Spohn Ministry, Corpus Christi, Texas, 78404, United States|Dallas VA Medical Center, Dallas, Texas, 75216, United States|Texas Oncology- Baylor Charles A. Sammons Cancer Center, Dallas, Texas, 75246, United States|The University of Texas Southwestern Medical Center, Dallas, Texas, 75390, United States|Oncology Consultants, P.A., Houston, Texas, 77030, United States|Texas Oncology-McKinney, McKinney, Texas, 75071, United States|Texas Oncology - Paris, Paris, Texas, 75460, United States|Texas Oncology- Plano West, Plano, Texas, 75093, United States|Baylor Scott & White Health/McClinton Cancer Center, Waco, Texas, 76712, United States|Texas Oncology-Waco, Waco, Texas, 76712, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, 84112, United States|Overlake Medical Center & Clinics, Bellevue, Washington, 98004, United States|UW Carbone Cancer Center, Madison, Wisconsin, 53792, United States|Medical University Salzburg, State Hospital, University hospital for internal medicine III / PMU, Salzburg, 5020, Austria|Institut Jules Bordet - Department of Intensive Care and Thoracic Oncology, Brussels, 1000, Belgium|Clinique André Renard Herstal Oncologie, Herstal, 4040, Belgium|AZ Sint Maarten, Mechelen, 2800, Belgium|Complex Oncology Center (COC) - Plovdiv EOOD,, Plovdiv, 4004, Bulgaria|McGill University Health Centre, Montréal, Quebec, H4A 3J1, Canada|Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke (CIUSSS de l'Estrie - CHUS), Sherbrooke, Quebec, J1H 5N4, Canada|Allan Blair Cancer Center, Regina, Saskatchewan, S4T 7T1, Canada|Beijing Cancer Hospital, Beijing, Beijing, China|Affiliated Cancer Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China|Henan Cancer Hospital, Zhengzhou, Henan, 450003, China|Henan Provincial People's Hospital, Zhengzhou, Henan, 45003, China|PKUCare Luzhong Hospital, Zibo, Shandong, 250014, China|Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 31000, China|Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 311000, China|Sun Yat-sen University Cancer Center, Guangzhou, China|University Hospital Centre Zagreb, Zagreb, 10000, Croatia|General University Hospital in Prague, Prague, Czechia|Thomayerova Nemocnice Dept. of Pneumology, Prague, Czechia|Vitkovicka nemocnice, Vitkovice, Czechia|Centre Hospitalier de Beauvais, Beauvais, 60021, France|INSTITUT BERGONIE Centre Régional de Lutte Contre le Cancer, Bordeaux, France|Groupe Hospitalier Bretagne Sud, Lorient, 56100, France|CHU Caremeau Service de Pneumologie, Nîmes, 30029, France|AH-HP Hôpital Saint Louis, Paris, France|Centre Hospitalier de Saint-Quentin Service de pneumologie, Saint-Quentin, 21000, France|Universitätsklinikum Halle - Universitätsklinik und Poliklinik für Innere Medizin IV, Halle (Saale), Germany|Queen Mary Hospital, Hong Kong, Hong Kong|Tolna County, Balassa Janos Hospital, Department of oncology, Szekszárd, 7100, Hungary|ASL 3, Ospedale Villa Scassi, Genova, 16132, Italy|IRCCS - Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, Italy|UOC Oncologia Medica Presidio Ospedaliero di Ravenna AUSL della Romagna, Ravenna, Italy|Saronno Hospital, Saronno, 21047, Italy|St Jansdal Ziekenhuis, Harderwijk, Netherlands|Erasmus Mc, Rotterdam, 3015, Netherlands|Uniwersyteckie Centrum Kliniczne, Gdansk, Poland|MS Clinsearch Specjalistyczny NZOZ, Lublin, Poland|Clinical Hospital of Przemienienia Pańskiego UM in Poznaniu, Poznan, Poland|Samodzielny Publiczny Wojewódzki Szpital Zespolony w Szczecinie, Szczecin, 70-891, Poland|Centrum Terapii Współczesnej, Łódź, Poland|Bezanijska kosa Clinical Hospital Center, Belgrade, 11080, Serbia|University Clinical Center Kragujevac, Kragujevac, 34000, Serbia|Hospital Universitario Arnau de Vilanova, Lleida, Catalonia, Spain|Hospital Quirón Teknon, Instituto Oncológico Dr. Rosell, Barcelona, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario Puerta de Hierro, Madrid, Spain|Hospital Regional Universitario Carlos Haya Medical Oncology Department, Málaga, Spain|Hospital Virgen de la Salud, Toledo, 45071, Spain|Hospital Universitari i Politécnic La Fe, Valencia, Spain|Kantonsspital Winterthur Tumorzentrum Winterthur, Winterthur, 8400, Switzerland",
